Transgenically expressed Parascaris P-glycoprotein-11 can modulate ivermectin susceptibility in Caenorhabditis elegans

Int J Parasitol Drugs Drug Resist. 2015 Apr 8;5(2):44-7. doi: 10.1016/j.ijpddr.2015.03.003. eCollection 2015 Aug.

Abstract

P-glycoproteins (Pgps) are suspected to mediate drug extrusion in nematodes contributing to macrocyclic lactone resistance. This association was recently shown for Parascaris Pgp-11. Ivermectin resistance was correlated with the presence of three pgp-11 single nucleotide polymorphisms and/or increased pgp-11 mRNA levels. In the present study, the ability of Pgp-11 to modulate ivermectin susceptibility was investigated by its expression in a pgp-11-deficient Caenorhabditis elegans strain. Expression of Parascaris pgp-11 in two transgenic lines significantly decreased ivermectin susceptibility in a motility (thrashing) assay conducted in liquid medium. The EC50 values increased by 3.2- and 4.6-fold in the two lines relative to a transgenic control strain. This is the first report on the successful functional analysis of a parasitic nematode Pgp in the model organism C. elegans.

Keywords: Caenorhabditis elegans; Equine parasites; Macrocyclic lactone; Resistance; Thrashing assay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B / genetics
  • ATP Binding Cassette Transporter, Subfamily B / metabolism*
  • Animals
  • Animals, Genetically Modified
  • Antiparasitic Agents / pharmacology
  • Ascaridoidea / genetics
  • Ascaridoidea / metabolism*
  • Caenorhabditis elegans / drug effects*
  • Caenorhabditis elegans / genetics
  • Caenorhabditis elegans / metabolism*
  • Drug Resistance*
  • Gene Expression Regulation
  • Ivermectin / pharmacology*

Substances

  • ATP Binding Cassette Transporter, Subfamily B
  • Antiparasitic Agents
  • Ivermectin